Annual CFI
$15.39 M
+$73.56 M+126.46%
31 December 2023
Summary:
Co-Diagnostics annual cash flow from investing activities is currently $15.39 million, with the most recent change of +$73.56 million (+126.46%) on 31 December 2023. During the last 3 years, it has risen by +$21.21 million (+364.22%). CODX annual CFI is now at all-time high.CODX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$4.17 M
+$8.20 M+203.27%
30 September 2024
Summary:
Co-Diagnostics quarterly cash flow from investing activities is currently $4.17 million, with the most recent change of +$8.20 million (+203.27%) on 30 September 2024. Over the past year, it has increased by +$1.83 million (+78.09%). CODX quarterly CFI is now -75.00% below its all-time high of $16.67 million, reached on 31 March 2024.CODX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$26.42 M
+$1.83 M+7.43%
30 September 2024
Summary:
Co-Diagnostics TTM cash flow from investing activities is currently $26.42 million, with the most recent change of +$1.83 million (+7.43%) on 30 September 2024. Over the past year, it has increased by +$73.95 million (+155.58%). CODX TTM CFI is now -37.51% below its all-time high of $42.28 million, reached on 31 March 2024.CODX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CODX Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +126.5% | +78.1% | +155.6% |
| 3 y3 years | +364.2% | +379.2% | +518.2% |
| 5 y5 years | +4146.5% | +4410.6% | +4232.7% |
CODX Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +126.5% | -75.0% | +107.8% | -37.5% | +138.2% |
| 5 y | 5 years | at high | +126.5% | -75.0% | +107.8% | -37.5% | +138.2% |
| alltime | all time | at high | +126.5% | -75.0% | +107.8% | -37.5% | +138.2% |
Co-Diagnostics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $4.17 M(-203.3%) | $26.42 M(+7.4%) |
| June 2024 | - | -$4.04 M(-124.2%) | $24.59 M(-41.8%) |
| Mar 2024 | - | $16.67 M(+73.4%) | $42.28 M(+174.7%) |
| Dec 2023 | $15.39 M(-126.5%) | $9.62 M(+310.8%) | $15.39 M(-132.4%) |
| Sept 2023 | - | $2.34 M(-82.9%) | -$47.53 M(+5.3%) |
| June 2023 | - | $13.65 M(-233.6%) | -$45.13 M(-34.8%) |
| Mar 2023 | - | -$10.21 M(-80.8%) | -$69.24 M(+19.0%) |
| Dec 2022 | -$58.17 M(-1519.2%) | -$53.31 M(-1224.8%) | -$58.17 M(+1434.5%) |
| Sept 2022 | - | $4.74 M(-145.3%) | -$3.79 M(-50.5%) |
| June 2022 | - | -$10.46 M(-1318.0%) | -$7.66 M(-398.7%) |
| Mar 2022 | - | $858.70 K(-19.8%) | $2.56 M(-37.4%) |
| Dec 2021 | $4.10 M(-170.4%) | $1.07 M(+23.1%) | $4.10 M(-4.1%) |
| Sept 2021 | - | $869.80 K(-470.3%) | $4.27 M(-255.6%) |
| June 2021 | - | -$234.90 K(-109.8%) | -$2.75 M(-13.7%) |
| Mar 2021 | - | $2.39 M(+92.1%) | -$3.18 M(-45.4%) |
| Dec 2020 | -$5.82 M | $1.25 M(-120.3%) | -$5.82 M(-18.1%) |
| Sept 2020 | - | -$6.15 M(+818.8%) | -$7.11 M(+573.6%) |
| June 2020 | - | -$669.40 K(+167.3%) | -$1.06 M(+72.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$250.40 K(+545.4%) | -$613.70 K(+41.0%) |
| Dec 2019 | -$435.20 K(+14.4%) | -$38.80 K(-59.9%) | -$435.30 K(-31.9%) |
| Sept 2019 | - | -$96.70 K(-57.6%) | -$639.30 K(+4.7%) |
| June 2019 | - | -$227.80 K(+216.4%) | -$610.40 K(+42.8%) |
| Mar 2019 | - | -$72.00 K(-70.3%) | -$427.60 K(+12.4%) |
| Dec 2018 | -$380.30 K(+100.9%) | -$242.80 K(+258.1%) | -$380.30 K(+61.3%) |
| Sept 2018 | - | -$67.80 K(+50.7%) | -$235.80 K(+37.6%) |
| June 2018 | - | -$45.00 K(+82.2%) | -$171.40 K(-0.9%) |
| Mar 2018 | - | -$24.70 K(-74.9%) | -$173.00 K(-8.6%) |
| Dec 2017 | -$189.30 K(+1451.6%) | -$98.30 K(+2791.2%) | -$189.30 K(+97.8%) |
| Sept 2017 | - | -$3400.00(-92.7%) | -$95.70 K(+3.7%) |
| June 2017 | - | -$46.60 K(+13.7%) | -$92.30 K(+73.5%) |
| Mar 2017 | - | -$41.00 K(+772.3%) | -$53.20 K(+336.1%) |
| Dec 2016 | -$12.20 K(-88.9%) | -$4700.00(<-9900.0%) | -$12.20 K(+62.7%) |
| Sept 2016 | - | $0.00(-100.0%) | -$7500.00(0.0%) |
| June 2016 | - | -$7500.00(<-9900.0%) | -$7500.00(<-9900.0%) |
| Mar 2016 | - | $0.00 | $0.00 |
| Dec 2015 | -$110.30 K | - | - |
FAQ
- What is Co-Diagnostics annual cash flow from investing activities?
- What is the all time high annual CFI for Co-Diagnostics?
- What is Co-Diagnostics annual CFI year-on-year change?
- What is Co-Diagnostics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Co-Diagnostics?
- What is Co-Diagnostics quarterly CFI year-on-year change?
- What is Co-Diagnostics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Co-Diagnostics?
- What is Co-Diagnostics TTM CFI year-on-year change?
What is Co-Diagnostics annual cash flow from investing activities?
The current annual CFI of CODX is $15.39 M
What is the all time high annual CFI for Co-Diagnostics?
Co-Diagnostics all-time high annual cash flow from investing activities is $15.39 M
What is Co-Diagnostics annual CFI year-on-year change?
Over the past year, CODX annual cash flow from investing activities has changed by +$73.56 M (+126.46%)
What is Co-Diagnostics quarterly cash flow from investing activities?
The current quarterly CFI of CODX is $4.17 M
What is the all time high quarterly CFI for Co-Diagnostics?
Co-Diagnostics all-time high quarterly cash flow from investing activities is $16.67 M
What is Co-Diagnostics quarterly CFI year-on-year change?
Over the past year, CODX quarterly cash flow from investing activities has changed by +$1.83 M (+78.09%)
What is Co-Diagnostics TTM cash flow from investing activities?
The current TTM CFI of CODX is $26.42 M
What is the all time high TTM CFI for Co-Diagnostics?
Co-Diagnostics all-time high TTM cash flow from investing activities is $42.28 M
What is Co-Diagnostics TTM CFI year-on-year change?
Over the past year, CODX TTM cash flow from investing activities has changed by +$73.95 M (+155.58%)